Summary

The global market for Hemostatic Valves was estimated to be worth US$ 160 million in 2024 and is forecast to a readjusted size of US$ 228 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Hemostatic Valves cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global Hemostasis valves production reached 55.28 million untis, with an average global market price of around US$ 2.89 per unit. Hemostasis valves, which is used primarily in interventional cardiology and angioplasty procedures. Designed to minimize fluid loss and backflow, the valves are available in a range of styles with a variety of features.

The annual production capacity of a single hemostasis valve production line predominantly ranges from 700,000 to 2 million units. Large-scale enterprises achieve this capacity through highly automated production lines while maintaining profitability with gross margins of 40% to 50%. Leading companies, utilizing multiple production lines, have established an annual production capacity reaching tens of millions of units, accounting for over 50% of the global market share. Their capacity advantage directly reduces unit production costs and strengthens their market position. Capacity allocation and cost control capabilities have become core competitive factors in the industry, directly determining profitability in a market with an average unit price of $2.89.

This report aims to provide a comprehensive presentation of the global market for Hemostatic Valves, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hemostatic Valves by region & country, by Type, and by Application.
The Hemostatic Valves market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Valves.

Market Segmentation
By Company
Boston Scientific
Freudenberg Medical
Argon Medical
DeRoyal Industries, Inc.
Teleflex
Galt Medical Corp.
Scitech
Medtronic
Excel Medical Products
Merit Medical Systems
Elcam Medical
Abbott
Segment by Type
Hemostasis Valve Y-Connectors
Double Y-Connector Hemostasis Valves
One-Handed Hemostasis Valves
Others
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hemostatic Valves manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hemostatic Valves in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hemostatic Valves in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Hemostatic Valves Product Introduction
1.2 Global Hemostatic Valves Market Size Forecast
1.2.1 Global Hemostatic Valves Sales Value (2020-2031)
1.2.2 Global Hemostatic Valves Sales Volume (2020-2031)
1.2.3 Global Hemostatic Valves Sales Price (2020-2031)
1.3 Hemostatic Valves Market Trends & Drivers
1.3.1 Hemostatic Valves Industry Trends
1.3.2 Hemostatic Valves Market Drivers & Opportunity
1.3.3 Hemostatic Valves Market Challenges
1.3.4 Hemostatic Valves Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hemostatic Valves Players Revenue Ranking (2024)
2.2 Global Hemostatic Valves Revenue by Company (2020-2025)
2.3 Global Hemostatic Valves Players Sales Volume Ranking (2024)
2.4 Global Hemostatic Valves Sales Volume by Company Players (2020-2025)
2.5 Global Hemostatic Valves Average Price by Company (2020-2025)
2.6 Key Manufacturers Hemostatic Valves Manufacturing Base and Headquarters
2.7 Key Manufacturers Hemostatic Valves Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hemostatic Valves
2.9 Hemostatic Valves Market Competitive Analysis
2.9.1 Hemostatic Valves Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Hemostatic Valves Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic Valves as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hemostasis Valve Y-Connectors
3.1.2 Double Y-Connector Hemostasis Valves
3.1.3 One-Handed Hemostasis Valves
3.1.4 Others
3.2 Global Hemostatic Valves Sales Value by Type
3.2.1 Global Hemostatic Valves Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Hemostatic Valves Sales Value, by Type (2020-2031)
3.2.3 Global Hemostatic Valves Sales Value, by Type (%) (2020-2031)
3.3 Global Hemostatic Valves Sales Volume by Type
3.3.1 Global Hemostatic Valves Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Hemostatic Valves Sales Volume, by Type (2020-2031)
3.3.3 Global Hemostatic Valves Sales Volume, by Type (%) (2020-2031)
3.4 Global Hemostatic Valves Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Hemostatic Valves Sales Value by Application
4.2.1 Global Hemostatic Valves Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Hemostatic Valves Sales Value, by Application (2020-2031)
4.2.3 Global Hemostatic Valves Sales Value, by Application (%) (2020-2031)
4.3 Global Hemostatic Valves Sales Volume by Application
4.3.1 Global Hemostatic Valves Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Hemostatic Valves Sales Volume, by Application (2020-2031)
4.3.3 Global Hemostatic Valves Sales Volume, by Application (%) (2020-2031)
4.4 Global Hemostatic Valves Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Hemostatic Valves Sales Value by Region
5.1.1 Global Hemostatic Valves Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Hemostatic Valves Sales Value by Region (2020-2025)
5.1.3 Global Hemostatic Valves Sales Value by Region (2026-2031)
5.1.4 Global Hemostatic Valves Sales Value by Region (%), (2020-2031)
5.2 Global Hemostatic Valves Sales Volume by Region
5.2.1 Global Hemostatic Valves Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Hemostatic Valves Sales Volume by Region (2020-2025)
5.2.3 Global Hemostatic Valves Sales Volume by Region (2026-2031)
5.2.4 Global Hemostatic Valves Sales Volume by Region (%), (2020-2031)
5.3 Global Hemostatic Valves Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Hemostatic Valves Sales Value, 2020-2031
5.4.2 North America Hemostatic Valves Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Hemostatic Valves Sales Value, 2020-2031
5.5.2 Europe Hemostatic Valves Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Hemostatic Valves Sales Value, 2020-2031
5.6.2 Asia Pacific Hemostatic Valves Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Hemostatic Valves Sales Value, 2020-2031
5.7.2 South America Hemostatic Valves Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hemostatic Valves Sales Value, 2020-2031
5.8.2 Middle East & Africa Hemostatic Valves Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hemostatic Valves Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Hemostatic Valves Sales Value and Sales Volume
6.2.1 Key Countries/Regions Hemostatic Valves Sales Value, 2020-2031
6.2.2 Key Countries/Regions Hemostatic Valves Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Hemostatic Valves Sales Value, 2020-2031
6.3.2 United States Hemostatic Valves Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Hemostatic Valves Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Hemostatic Valves Sales Value, 2020-2031
6.4.2 Europe Hemostatic Valves Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Hemostatic Valves Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Hemostatic Valves Sales Value, 2020-2031
6.5.2 China Hemostatic Valves Sales Value by Type (%), 2024 VS 2031
6.5.3 China Hemostatic Valves Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Hemostatic Valves Sales Value, 2020-2031
6.6.2 Japan Hemostatic Valves Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Hemostatic Valves Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Hemostatic Valves Sales Value, 2020-2031
6.7.2 South Korea Hemostatic Valves Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Hemostatic Valves Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Hemostatic Valves Sales Value, 2020-2031
6.8.2 Southeast Asia Hemostatic Valves Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Hemostatic Valves Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Hemostatic Valves Sales Value, 2020-2031
6.9.2 India Hemostatic Valves Sales Value by Type (%), 2024 VS 2031
6.9.3 India Hemostatic Valves Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Company Information
7.1.2 Boston Scientific Introduction and Business Overview
7.1.3 Boston Scientific Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Boston Scientific Hemostatic Valves Product Offerings
7.1.5 Boston Scientific Recent Development
7.2 Freudenberg Medical
7.2.1 Freudenberg Medical Company Information
7.2.2 Freudenberg Medical Introduction and Business Overview
7.2.3 Freudenberg Medical Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Freudenberg Medical Hemostatic Valves Product Offerings
7.2.5 Freudenberg Medical Recent Development
7.3 Argon Medical
7.3.1 Argon Medical Company Information
7.3.2 Argon Medical Introduction and Business Overview
7.3.3 Argon Medical Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Argon Medical Hemostatic Valves Product Offerings
7.3.5 Argon Medical Recent Development
7.4 DeRoyal Industries, Inc.
7.4.1 DeRoyal Industries, Inc. Company Information
7.4.2 DeRoyal Industries, Inc. Introduction and Business Overview
7.4.3 DeRoyal Industries, Inc. Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 DeRoyal Industries, Inc. Hemostatic Valves Product Offerings
7.4.5 DeRoyal Industries, Inc. Recent Development
7.5 Teleflex
7.5.1 Teleflex Company Information
7.5.2 Teleflex Introduction and Business Overview
7.5.3 Teleflex Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Teleflex Hemostatic Valves Product Offerings
7.5.5 Teleflex Recent Development
7.6 Galt Medical Corp.
7.6.1 Galt Medical Corp. Company Information
7.6.2 Galt Medical Corp. Introduction and Business Overview
7.6.3 Galt Medical Corp. Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Galt Medical Corp. Hemostatic Valves Product Offerings
7.6.5 Galt Medical Corp. Recent Development
7.7 Scitech
7.7.1 Scitech Company Information
7.7.2 Scitech Introduction and Business Overview
7.7.3 Scitech Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Scitech Hemostatic Valves Product Offerings
7.7.5 Scitech Recent Development
7.8 Medtronic
7.8.1 Medtronic Company Information
7.8.2 Medtronic Introduction and Business Overview
7.8.3 Medtronic Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Medtronic Hemostatic Valves Product Offerings
7.8.5 Medtronic Recent Development
7.9 Excel Medical Products
7.9.1 Excel Medical Products Company Information
7.9.2 Excel Medical Products Introduction and Business Overview
7.9.3 Excel Medical Products Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Excel Medical Products Hemostatic Valves Product Offerings
7.9.5 Excel Medical Products Recent Development
7.10 Merit Medical Systems
7.10.1 Merit Medical Systems Company Information
7.10.2 Merit Medical Systems Introduction and Business Overview
7.10.3 Merit Medical Systems Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Merit Medical Systems Hemostatic Valves Product Offerings
7.10.5 Merit Medical Systems Recent Development
7.11 Elcam Medical
7.11.1 Elcam Medical Company Information
7.11.2 Elcam Medical Introduction and Business Overview
7.11.3 Elcam Medical Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Elcam Medical Hemostatic Valves Product Offerings
7.11.5 Elcam Medical Recent Development
7.12 Abbott
7.12.1 Abbott Company Information
7.12.2 Abbott Introduction and Business Overview
7.12.3 Abbott Hemostatic Valves Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Abbott Hemostatic Valves Product Offerings
7.12.5 Abbott Recent Development
8 Industry Chain Analysis
8.1 Hemostatic Valves Industrial Chain
8.2 Hemostatic Valves Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hemostatic Valves Sales Model
8.5.2 Sales Channel
8.5.3 Hemostatic Valves Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer